Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.60B | $3.64B | $4.31B | $4.87B | $4.88B | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B |
| Revenue growth | — | 1.4% | 18.2% | 13.0% | 0.3% | -4.0% | 7.0% | 11.1% | 9.9% | 6.4% |
| Operating income | $2.20B | $2.31B | $2.61B | $2.59B | $2.64B | $2.65B | $3.02B | $3.44B | $3.93B | $4.23B |
| Operating margin | 61.2% | 63.4% | 60.5% | 53.2% | 54.0% | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% |
| Net income | $1.53B | $4.06B | $1.96B | $2.12B | $2.11B | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B |
| Net margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
| EPS (diluted) | $4.53 | $11.94 | $5.71 | $5.91 | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.73B | $1.75B | $2.44B | $2.67B | $2.72B | $2.40B | $3.06B | $3.45B | $3.69B | $4.28B |
| Capital expenditures | $91.8M | $81.9M | $117M | $246M | $198M | $127M | $89.7M | $76.4M | $94.0M | $83.5M |
| Free cash flow | $1.64B | $1.67B | $2.32B | $2.43B | $2.52B | $2.28B | $2.97B | $3.38B | $3.60B | $4.19B |
| Dividends paid | $1.79B | $1.99B | $2.15B | $1.70B | $2.11B | $2.19B | $2.63B | $3.24B | $3.58B | $3.93B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.87B | $1.90B | $1.37B | $1.55B | $1.63B | $2.83B | $2.72B | $2.91B | $2.89B | $4.42B |
| Total assets | $69.4B | $75.8B | $77.5B | $75.2B | $125B | $197B | $174B | $130B | $137B | $198B |
| Total liabilities | $49.0B | $53.4B | $51.5B | $49.1B | $98.3B | $169B | $147B | $103B | $111B | $170B |
| Shareholders' equity | $20.3B | $22.4B | $25.9B | $26.1B | $26.3B | $27.4B | $26.9B | $26.7B | $26.5B | $28.7B |
| Retained earnings | $2.52B | $4.50B | $4.86B | $5.01B | $5.00B | $5.15B | $4.75B | $4.46B | $4.19B | $6.43B |
| Shares (wtd avg diluted) | 339M | 340M | 344M | 358M | 359M | 359M | 359M | 360M | 360M | 360M |
Every figure is extracted from CME GROUP INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.